142 related articles for article (PubMed ID: 21216537)
1. Infectious atherosclerosis: is the hypothesis still alive? A clinically based approach to the dilemma.
Alviar CL; Echeverri JG; Jaramillo NI; Figueroa CJ; Cordova JP; Korniyenko A; Suh J; Paniz-Mondolfi A
Med Hypotheses; 2011 Apr; 76(4):517-21. PubMed ID: 21216537
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of Chlamydophila pneumoniae, Mycoplasma pneumoniae, Cytomegalovirus, and Epstein-Barr virus in atherosclerotic coronary arteries, nonrheumatic calcific aortic and rheumatic stenotic mitral valves by polymerase chain reaction.
Bayram A; Erdoğan MB; Ekşi F; Yamak B
Anadolu Kardiyol Derg; 2011 May; 11(3):237-43. PubMed ID: 21466993
[TBL] [Abstract][Full Text] [Related]
3. Detection of infectious agents by polymerase chain reaction in human aortic wall.
Reszka E; Jegier B; Wasowicz W; Lelonek M; Banach M; Jaszewski R
Cardiovasc Pathol; 2008; 17(5):297-302. PubMed ID: 18402822
[TBL] [Abstract][Full Text] [Related]
4. Co-infection ratios versus inflammation, growth factors and progression of early atheromas.
Higuchi ML; Góis JM; Reis MM; Higuchi-Dos-Santos MH; Diament J; Sousa JM; Ramires JA; Oliveira SA
APMIS; 2006 May; 114(5):338-44. PubMed ID: 16725009
[TBL] [Abstract][Full Text] [Related]
5. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients.
Jha HC; Srivastava P; Divya A; Prasad J; Mittal A
APMIS; 2009 Dec; 117(12):905-11. PubMed ID: 20078556
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic therapy for coronary heart disease: the myth and the reality.
Kuppuswamy VC; Gupta S
Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482
[TBL] [Abstract][Full Text] [Related]
8. [Mycoplasma pneumoniae and Chlamydophila pneumoniae coinfection in severe pneumoniae among a hospitalized child with respiratory distress: what are the best diagnostic tools for an optimal care?].
Petitjean-Lecherbonnier J; Dina J; Gouarin S; Kozisek S; Poveda JD; Vabret A
Pathol Biol (Paris); 2010 Dec; 58(6):434-6. PubMed ID: 19375247
[TBL] [Abstract][Full Text] [Related]
9. [Infection and coronary atherosclerosis: the role Chlamydia pneumonia].
Paz M; de Otero J; Codinach P; Ferrer-Ruscalleda F; Gayà M; Ibernón M
Rev Esp Cardiol; 1998 Nov; 51(11):857-63. PubMed ID: 9859707
[TBL] [Abstract][Full Text] [Related]
10. Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases.
Teig N; Anders A; Schmidt C; Rieger C; Gatermann S
Thorax; 2005 Nov; 60(11):962-6. PubMed ID: 16143584
[TBL] [Abstract][Full Text] [Related]
11. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?
Johnston SL; Martin RJ
Am J Respir Crit Care Med; 2005 Nov; 172(9):1078-89. PubMed ID: 15961690
[TBL] [Abstract][Full Text] [Related]
12. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target.
Ismail A; Khosravi H; Olson H
Heart Dis; 1999; 1(4):233-40. PubMed ID: 11720630
[TBL] [Abstract][Full Text] [Related]
13. [A case of pneumonia due to coinfection by Mycoplasma pneumoniae and Chlamydia pneumoniae].
Sasaki M; Sano M; Sato K; Fukui S; Izumiyama N; Ito T; Kashima M; Kagaya M; Miura M
Nihon Kokyuki Gakkai Zasshi; 2002 Dec; 40(12):960-4. PubMed ID: 12692948
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating Chlamydophila pneumoniae in patients with coronary artery disease and healthy control subjects.
West SK; Kohlhepp SJ; Jin R; Gleaves CA; Stamm W; Gilbert DN
Clin Infect Dis; 2009 Mar; 48(5):560-7. PubMed ID: 19191640
[TBL] [Abstract][Full Text] [Related]
15. Use of quantitative and objective enzyme immunoassays to investigate the possible association between Chlamydia pneumoniae and Mycoplasma pneumoniae antibodies and asthma.
Tuuminen T; Edelstein I; Punin A; Kislova N; Stratchounski L
Clin Microbiol Infect; 2004 Apr; 10(4):345-8. PubMed ID: 15059128
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
Campbell LA; Kuo CC
Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
[TBL] [Abstract][Full Text] [Related]
17. Mycoplasma pneumoniae and asthma in children.
Biscardi S; Lorrot M; Marc E; Moulin F; Boutonnat-Faucher B; Heilbronner C; Iniguez JL; Chaussain M; Nicand E; Raymond J; Gendrel D
Clin Infect Dis; 2004 May; 38(10):1341-6. PubMed ID: 15156467
[TBL] [Abstract][Full Text] [Related]
18. [Detection and treatment of Chlamydia and Mycoplasma infections in patients with bronchoobstructive diseases].
Kasimtseva SA; Stepanian IE; Lovacheva OV; Shmelev EI
Probl Tuberk Bolezn Legk; 2006; (2):28-31. PubMed ID: 16610307
[No Abstract] [Full Text] [Related]
19. [Chlamydia pneumoniae antibodies and other atherosclerosis risk factors in haemodialysed patients. Preliminary report].
Prokopiuk M; Wierzbicki P; Kade G; Dudko S; Wańkowicz Z
Pol Merkur Lekarski; 2002 Nov; 13(77):380-3. PubMed ID: 12621753
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.
Higgins JP
Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
